Man Group
CTMX icon

Man Group’s CytomX Therapeutics CTMX Stock Holding History

Man Group’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-191,060
Closed -$417K – 2063
2024
Q1 		$417K Buy
+191,060
New +$353K ﹤0.01% 1845
2023
Q1 		– Sell
-34,575
Closed -$78.1K – 1986
2022
Q4 		$55.3K Buy
34,575
+9,145
+36% +$13.5K ﹤0.01% 1956
2022
Q3 		$36K Buy
+25,430
New +$39.1K ﹤0.01% 1916
2022
Q2 		– Hold
0
– – – 1935
2021
Q2 		– Sell
-45,988
Closed -$355K – 1978
2021
Q1 		$355K Sell
45,988
-220,998
-83% -$1.75M ﹤0.01% 1589
2020
Q4 		$1.75M Buy
266,986
+45,174
+20% +$323K 0.01% 1247
2020
Q3 		$1.48M Buy
221,812
+27,400
+14% +$203K 0.01% 1283
2020
Q2 		$1.62M Sell
194,412
-77,998
-29% -$724K 0.01% 1129
2020
Q1 		$2.09M Sell
272,410
-48,245
-15% -$336K 0.01% 868
2019
Q4 		$2.67M Buy
320,655
+310,309
+2,999% +$2.09M 0.01% 1240
2019
Q3 		$76K Buy
+10,346
New +$102K ﹤0.01% 1745
2019
Q2 		– Sell
-81,798
Closed -$879K – 1899
2019
Q1 		$879K Sell
81,798
-55,463
-40% -$820K ﹤0.01% 1611
2018
Q4 		$2.07M Sell
137,261
-38,899
-22% -$577K 0.01% 1207
2018
Q3 		$3.26M Sell
176,160
-185,590
-51% -$4.23M 0.01% 1209
2018
Q2 		$8.27M Sell
361,750
-45,733
-11% -$1.17M 0.03% 682
2018
Q1 		$11.6M Buy
+407,483
New +$11.6M 0.05% 415

Other funds holding CTMX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Man Group's CTMX Position: Q2 2024 in Review

Man Group sold out of CytomX Therapeutics (CTMX) in Q2 2024, closing a stake of 191,060 shares — an estimated $417K sold.

Man Group first reported a position in CTMX in Q1 2018 and held it in 15 quarters. The position peaked at $11.6M in Q1 2018. 74 funds tracked by Wall St. Rank hold CTMX as of Q2 2024.

  • Man Group reported no remaining CytomX Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Man Group sold 191,060 CytomX Therapeutics shares in Q2 2024, an estimated $417K.
  • Man Group first reported a position in CytomX Therapeutics in Q1 2018 and held it in 15 quarters.
  • Man Group's CytomX Therapeutics position peaked at $11.6M in Q1 2018.
  • 74 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2024.

Based on Man Group's 13F filing for Q2 2024, filed 14 Aug 2024.